New biomarker may predict leukemia aggressiveness

April 20, 2009

Scientists at the University of California, San Diego and the Moores UCSD Cancer Center have evidence of a potential new biomarker to predict the aggressiveness of an often difficult-to-treat form of leukemia. They found that high levels of a particular enzyme in the blood are an indicator that chronic lymphocytic leukemia (CLL) -- the most common form of adult leukemia -- will be aggressive and in need of immediate treatment.

The researchers, led by Paul A. Insel, MD, professor of pharmacology and medicine at the UC San Diego School of Medicine, say that the enzyme, PDE7B, is also critical to the development of CLL and a potential target for drugs against the disease. They present their results April 19, 2009 at the AACR 100th Annual Meeting 2009 in Denver.

One of the problems in deciding on the right therapy for CLL is that it is difficult to know which type of leukemia a patient has. One form progresses slowly, with few symptoms for years while the other form is more aggressive and dangerous. While tests exist and are commonly used to help doctors predict which form a patient may have, their availability and usefulness are limited.

In previous work, Insel's group had discovered that among a group of enzymes, cyclic nucleotide phosphodiesterases, one of the phosphodiesterases, PDE7B, was 10 times higher in CLL patients than in healthy individuals. PDE7B controls the levels of cyclic AMP (cAMP), a molecule that can promote programmed cell death, a process that is defective in CLL. Whereas most cancers have out-of-control cell growth, CLL is characterized by an overabundance of white blood cells that do not die when they should. High levels of PDE7B mean less cAMP and as a result, less cell death.

"The question was, could the level of PDE7B expression provide evidence for the clinical stage and diagnosis for individual patients?" Insel said. To find out if changes in PDE7B levels might reflect disease progression, Insel, postodoctoral fellow Linghzi Zhang, PhD, and their co-workers compared the amount of PDE7B in white blood cells in 85 untreated patients with CLL to those of 30 healthy adults, and watched for changes over time. They then divided the results into patients who had high levels of PDE7B and those who had low amounts.

"We found that individuals with high levels really had worse disease and showed that PDE7B expression had predictive value relative to other currently available markers for disease severity and progression," Insel said. "In some cases, the level of PDE7B expression provided prognostic information that was additive to existing markers."

Zhang said that PDE7B can be used alone as a biomarker for CLL if the levels are high enough, but may be used with other markers if the level is lower and ambiguous. "PDE7B may not be good enough by itself if it's not high enough," she noted. "If it is low, other markers could be helpful."

Co-investigator and leukemia expert Thomas Kipps, MD, PhD, professor of medicine and deputy director for research at the Moores UCSD Cancer Center, said that the findings are potentially important because of the urgency for clinicians to be able to gauge early on what kind of disease the CLL patient has in order to design the best available therapy.

Insel said that their research to date implies that PDE7B has a role in prognosis and could also be a good drug target because it reflects part of the biology of the disease. "The more of this enzyme a patient has, the worse the outcome," he said. "This implies that if we can develop drugs to block this enzyme, which would raise cAMP and promote apoptosis -- which is really at the heart of the underlying pathology."

University of California - San Diego

---

---

	Johns Hopkins Patients' Guide to Leukemia by Candis Morrison (Author), Charles L. Hesdorffer (Author) Johns Hopkins Patients' Guide to Leukemia is a concise, easy-to-follow how to guide that puts you on a path to wellness by explaining leukemia treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in layman s terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	Journey to the Edge of the Light: A Story of Love, Leukemia and Transformation (Kindle Single) (Kindle Singles) She was a romantic and a globetrotter, a daredevil and a writer on the edge of literary fame. Then her life was irreversibly transformed—and so was her philosophy. In this wholly unexpected personal account, the author of A Vindication of Love: Reclaiming Romance for the Twenty-first Century (2009) offers us a Vindication of Life as inspiring as it is heartbreaking. The story of Cristina and her little daughter, Eurydice, is a tale of redemption and self-reinvention. It is about expanding definitions of love--and it is about confronting death. Not least, it speaks to us of life’s sweeping ironies: Sometimes bad luck is the new good luck, and the realization of your worst fears may be the greatest gift you can receive. Biography: Nehring first acquired national...
	Childhood Leukemia: A guide for Families, Friends & Caregivers (Patient Centered Guides) by Nancy Keene (Author) This most complete parent guide covers not only detailed and precise medical information about leukemia and the various treatment options, but also day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven among the medical details and the practical advice are the voices of more than 150 parents and children who have lived with leukemia and its treatments. As many parents have already found, advice from "veteran" parents can be a lifeline. Obtaining a basic understanding of topics such as medical terminology, common side effects of chemotherapy, and how to interpret blood counts can help improve...
	Leukemia: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Leukemia - Revised Edition - Illustrated by S. Smith by Department of Health and Human Services (Author), National Institutes of Health (Author), National Cancer Institute (Author), S. Smith (Editor), S. Smith (Editor) This Leukemia Book is the revised version of the popular original version titled " Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Leukemia ", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Leukemia, with information on getting help and coping. This booklet is also for family and friends that are looking for further understanding of Leukemia. You will learn in this Booklet: What Is Leukemia? Types of Leukemia...
	Living through the Racket: How I Survived Leukemia.and Rediscovered My Self by Corina Morariu (Author), Allen Rucker (Author), Billie Jean King (Foreword) She was 23 and at the height of her professional tennis career—a top-30 singles player, the #1 ranked doubles player in the world in 2000, and the winner of Grand Slam titles at both Wimbledon in 1999 with Lindsay Davenport, and the Australian Open Mixed doubles in 2001. Then, in May 2001, Corina Morariu was diagnosed with an advanced form of acute myelogenous leukemia and found herself in the match of a lifetime. After a grueling regimen of chemotherapy, Corina returned to competitive tennis 16 months after her diagnosis. She was named the WTA Tour Comeback Player of the Year in 2002, but the effects of the leukemia lingered. On the court, she struggled to come to terms with the cancer and two subsequent shoulder surgeries that diminished her physical capabilities as a tennis player....
	100 Questions & Answers About Leukemia by Edward D. Ball (Author), Alex Kagan (Author) EMPOWER YOURSELF! Whether You’Re A Newly Diagnosed Leukemia Patient, A Survivor, Or A Friend Or Relative Of Either, This Book Offers Help. The Only Text To Provide The Doctor And Patient’S View, 100 Questions & Answers About Leukemia, Second Edition Gives You An Updated And Authoritative Practical Answers To Your Questions About Treatment Options, Post-Treatment Quality Of Life, Sources Of Support, And Much More. Written By A Leukemia Survivor And A Prominent Physician Specializing In Treatment Of Leukemia, This Book Is An Invaluable Resource For Anyone Coping With The Physical And Emotional Turmoil Of This Frightening Disease.
	Simon's Choice: How can a father ever let go? by Charlotte Castle (Author) "But Daddy, who will live with me in heaven?" Doctor Simon Bailey has everything a man could ever want. Then his beautiful daughter is diagnosed with Leukemia. He can almost accept her impending death. He can almost accept the fact that he will have to live without her. But he cannot stand the thought of his little girl having to face death alone. He answers her innocent question in a moment of desperation, testing his marriage, his professional judgment and his sanity to the limit. As cracks form in Simon's previously perfect family, we wonder, as do his loved ones ... will he really make the ultimate sacrifice? Combining poignant moments of both humour and pain, 'Simon's Choice' is a penetrating account of parenthood at the sharp-end.
	Medifocus Guidebook on: Chronic Lymphocytic Leukemia by Inc. Medifocus.com (Author), Elliot Jacob PhD. (Editor) The MediFocus Guidebook on Chronic Lymphocytic Leukemia is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Chronic Lymphocytic Leukemia, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Chronic Lymphocytic Leukemia, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading...
	What You Need To Know About: Leukemia This booklet is about leukemia, cancer that starts in the tissue that forms blood. Each year in the United States, more than 40,800 adults and 3,500 children learn they have this disease. Learning about medical care for leukemia can help you take an active part in making choices about your care. This booklet tells about diagnosis, treatment options, supportive care you may need before, during, or after treatment, tests the doctor may give you during follow-up visits, taking part in research studies.
	Adult Leukemia: A Comprehensive Guide for Patients and Families by Barbara Lackritz (Author) Tens of thousands of Americans are living with adult leukemia, a cancer of the white blood cells. Adult leukemia, which is really a group of diseases, can be a baffling condition for patients and families to understand, and finding targeted information on individual conditions can be difficult. In straightforward, non-technical language, Adult Leukemia: A Comprehensive Guide for Patients and Families gives those living with leukemia the skills and resources to meet their needs for information and support. It addresses: Diagnosis and medical tests Finding, and successfully interacting with, a good oncologist Characteristics of the leukemias, factors in prognosis, and the various subtypes and staging systems for the disease Treatments, including watch-and-wait, chemotherapy, marrow...